SE7603325L - Beredning med retard-effekt - Google Patents

Beredning med retard-effekt

Info

Publication number
SE7603325L
SE7603325L SE7603325A SE7603325A SE7603325L SE 7603325 L SE7603325 L SE 7603325L SE 7603325 A SE7603325 A SE 7603325A SE 7603325 A SE7603325 A SE 7603325A SE 7603325 L SE7603325 L SE 7603325L
Authority
SE
Sweden
Prior art keywords
mixture
weight
gastric juice
formulation
preparation
Prior art date
Application number
SE7603325A
Other languages
Unknown language ( )
English (en)
Other versions
SE433804B (sv
Inventor
P R Sheth
J L Tossounian
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Publication of SE7603325L publication Critical patent/SE7603325L/sv
Publication of SE433804B publication Critical patent/SE433804B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7603325A 1975-03-17 1976-03-16 Forfarande for framstellning av en farmaceutisk lekemedelsberedning i kapselform med retardeffekt SE433804B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (2)

Publication Number Publication Date
SE7603325L true SE7603325L (sv) 1976-09-18
SE433804B SE433804B (sv) 1984-06-18

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7603325A SE433804B (sv) 1975-03-17 1976-03-16 Forfarande for framstellning av en farmaceutisk lekemedelsberedning i kapselform med retardeffekt

Country Status (21)

Country Link
JP (1) JPS51115910A (sv)
AR (1) AR222624A1 (sv)
AT (1) AT353415B (sv)
AU (1) AU505355B2 (sv)
CA (1) CA1073358A (sv)
CH (1) CH630257A5 (sv)
DD (1) DD124102A5 (sv)
DE (1) DE2611041A1 (sv)
DK (1) DK148344C (sv)
ES (1) ES446075A1 (sv)
FR (1) FR2304354A1 (sv)
GB (1) GB1546448A (sv)
GR (1) GR60341B (sv)
IE (1) IE43083B1 (sv)
LU (1) LU74558A1 (sv)
MC (1) MC1101A1 (sv)
NL (1) NL190313C (sv)
NZ (1) NZ180321A (sv)
PH (1) PH14927A (sv)
PT (1) PT64907B (sv)
SE (1) SE433804B (sv)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
NL8600161A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
NL194822C (nl) * 1985-10-01 2003-04-03 Novartis Ag Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
SK282071B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta dispergovateľná vo vode a spôsob jej prípravy
JP2626248B2 (ja) * 1991-04-08 1997-07-02 日本新薬株式会社 カプセル剤
ATE173159T1 (de) * 1992-03-25 1998-11-15 Depomed Systems Inc Auf hydroxyethylzellulose basierende oralen arzneidosisformen mit verzoegerter wirkstoffabgabe
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
CN1133558A (zh) * 1993-10-29 1996-10-16 雷克特和科尔曼产品有限公司 可发泡的明胶胶囊填充药物
WO1995011667A1 (en) * 1993-10-29 1995-05-04 R.P. Scherer Corporation Gelatin capsule fill able to foam
WO1995031186A1 (en) * 1994-05-13 1995-11-23 Smithkline Beecham Corporation Method and composition for increasing calcium uptake
JPH10509981A (ja) * 1994-12-01 1998-09-29 サイバス ファーマシューティカル，インコーポレイティド 高等植物から得られうる粉末状親水コロイドゴムを用いる持効性薬剤送出
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (sv) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Also Published As

Publication number Publication date
AR222624A1 (es) 1981-06-15
DD124102A5 (sv) 1977-02-02
IE43083L (en) 1976-09-17
DK148344B (da) 1985-06-17
DK113676A (da) 1976-09-18
FR2304354A1 (fr) 1976-10-15
DK148344C (da) 1985-11-04
FR2304354B1 (sv) 1979-04-27
JPS638084B2 (sv) 1988-02-19
PT64907B (fr) 1978-03-24
AU505355B2 (en) 1979-11-15
AU1204976A (en) 1977-09-22
JPS51115910A (en) 1976-10-13
CA1073358A (en) 1980-03-11
NL190313B (nl) 1993-08-16
GB1546448A (en) 1979-05-23
GR60341B (en) 1978-05-17
AT353415B (de) 1979-11-12
ATA192276A (de) 1979-04-15
NZ180321A (en) 1978-06-20
DE2611041A1 (de) 1976-10-14
ES446075A1 (es) 1977-09-16
MC1101A1 (fr) 1977-02-04
NL190313C (nl) 1994-01-17
NL7602776A (nl) 1976-09-21
LU74558A1 (sv) 1977-09-27
DE2611041C2 (sv) 1988-06-09
IE43083B1 (en) 1980-12-17
SE433804B (sv) 1984-06-18
PH14927A (en) 1982-01-29
CH630257A5 (en) 1982-06-15
PT64907A (fr) 1976-04-01

Similar Documents

Publication Publication Date Title
SE7603325L (sv) Beredning med retard-effekt
NO801490L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langtidsvirkning
NO178095C (no) Fremgangsmåte for fremstilling av et omhyllet farmasöytisk retarderingspreparat
IL57796A0 (en) Pharmaceutical compositions having retarded release of the active substance
ES2074698T3 (es) Composicion oral para el tratamiento de enfermedades intestinales inflamatorias.
EP0350701A3 (en) Pharmaceutical cmpositions for oral administration having analgesic and anti-inflammatory activity, possessing excellent palatability and being free of irritating effects on mucous membranes
SE8001599L (sv) Transdermalt medicineringssystem for isosorbiddinitrat
EP0135171A3 (en) Pharmaceutical composition for interferon application
NO139685C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolin-derivater
NO137899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider
GB2089210A (en) Polymeric diffusion matrix for administration of drugs
NO790523L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive 2-fenyliminoimidazolidiner
ZA772514B (en) Improvements relating to the administration of pharmaceutically active substances to animals
JPS5781409A (en) External plaster
DK78487D0 (da) Farmaceutisk praeparat indeholdende et i vand kvaeldende polymermateriale
NO141014C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 9-alkylamino-erytromyciner og deres salter
NO145950C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive homoftalimider
NO773344L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyridobenzodiazepinoner
JPS53148518A (en) Stabilized prostaglandin e composition and its preparation
JPS56169623A (en) Anti-inflammatory and pain-killing spreading plaster
NO137549C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(2-isopropyl)-indolyl-pyridylketonderivater
ES469840A1 (es) Procedimiento para la obtencion de nuevos derivados de tria-zolotiadiacinas.
JPS5626910A (en) Preparation of slow-release anticancer complex composition
JPS52130905A (en) Medicinal composition
JPS5242892A (en) Preparation of 1beta h, 13alpha h-9-oxabicyclo 11,3,0 hexadeca-3-ene derivative s

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: 7603325

NAL Patent in force

Ref document number: 7603325-7

SPCG Supplementary protection certificate granted

Free format text: 9490073, 920103, EXPIRES: 20010316

NUG Patent has lapsed

Ref document number: 7603325-7